Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway

Transplantation

Volumn 68, Issue 7, 1999, Pages 1010-1018

  Ossevoort, Miriam A ^a   Ringers, Jan ^b   Kuhn, Eva Maria ^a   Boon, Louis ^c   Lorré, Katrien ^d   Van Den Hout, Yvon ^a   Bruijn, Jan A ^b   De Boer, Mark ^c   Jonker, Margreet ^a   De Waele, Peter ^d  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Tanox Pharma BV   (Netherlands)

^d Innogenetics NV ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYCLOSPORIN; CYCLOSPORIN A; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; EPITOPES, T-LYMPHOCYTE; FEMALE; GRAFT REJECTION; ISOANTIGENS; KIDNEY; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES;

EID: 0033570195     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199910150-00019     Document Type: Article

References (38)

1. Krensky AM, Weiss A, Crabtree G, Davis MM, Parham P. T lymphocyte-antigen interaction in transplant rejection. N Engl J Med 1990; 322: 510.
2. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813.
3. Chambers CA, Allison JP Co-stimulation in T-cell responses. Curr Opin Immunol 1997; 9: 396.
4. Springer TA, Dustin ML, Kisshimoto S, Marlin D. The lymphocyte function associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors in the immune system. Annu Rev Immunol 1987; 5: 233.
5. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus clonal inactivation: a costimulatory signal pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7: 445.
6. Van Gool SW, Barcy S, Devos S, et al. CD80 (B7.1) and CD86 (B7.2): potential targets for immunotherapy? Res Immunol 1995; 146: 183.
7. Van Kooten C, Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 1997; 9: 330.
8. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4-Ig. Science 1992; 257: 789.
9. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
10. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
11. Woodward JE, Qin L, Chavin KD, et al. Blockade of multiple costimulatory receptors induces hyporesponsiveness. Transplantation 1996; 62: 1011.
12. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
13. Perico N, Imberti O, Bontempelli M, Remuzzi G. Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4-Ig. Kidney Int 1995; 47: 241.
14. Lenschow DJ, Zeng Y, Hatchcock KS, et al. Inhibition of transplant rejection following treatment with anti-B7.1 and anti-B7.2 antibodies. Transplantation 1995; 60: 1171.
15. Bashuda H, Seino K, Kano M, et al. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice. Transplant Proc 1996; 28: 1039.
16. Sopper S, Stahl-Hennig C, Demuth M, Johnston ICD, Dörries R, Ter Meulen V. Lymphocyte subsets and expression of differentiation markers in blood and lymphoid organs of rhesus monkeys. Cytometry 1997; 29: 351.
17. Jonker M, Goldstein G, Balner H. Effects of in vivo administration of monoclonal antibodies specific for human T cell sub-populations on the immune system in a rhesus monkey model. Transplantation 1983; 35: 521.
18. Jonker M, Neuhaus P, Zurcher C, Fucello A, Goldstein G. OKT4 and OKT4A antibody treatment as immunosuppression for kidney transplantation in rhesus monkeys. Transplantation 1985; 39: 247.
19. Zhang D, Johnson RP. Molecular cloning and comparative analysis of the rhesus macaque costimulatory molecules CD80 (B7-1) and CD86 (B7-2). Cell Immunol 1997; 177: 9.
20. Kirk AD, Harlan DM, Amstrong NN, et al. CTLA4-Ig and antiCD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94: 8789.
21. Ossevoort MA, De Boer M, Lorré K, VandeVoorde A, Jonker M. Blocking of costimulatory pathways using monoclonal antibodies as a new strategy to prevent transplant rejection in a non-human primate model. Transplant Proc 1998; 30: 1061.
22. Ossevoort MA, Lorré K, Boon L, et al. Prolonged skin graft survival by administration of anti-CD80 monoclonal antibody with cyclosporin A. J Immunother 1999; in press.
23. Bontrop RE, Otting N, Slierendregt BL, Lanchbury JS. Evolution of major histocompatibility complex polymorphisms and T-cell receptor diversity in primates. Immunol Rev 1995; 143: 33.
24. Mittal KK, Mickey MR, Singal DP, et al. Serotyping for homotransplantation. XVIII. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 1968; 6: 913.
25. Roger JJ, van Leeuwen A. The major histocompatibility complex of rhesus monkeys. VI. Serology and genetics of Ia-like antigens. Tissue Antigens 1976; 8: 67.
26. Dioxiades GGM, Otting N, Antunes SGM, et al. Characterisation of the ABO blood group genes in macaques: evidence for convergent evolution. Tissue Antigens 1998; 51: 321.
27. Neuhaus P, Neuhaus R, Wiersema HD, Borleffs JCC, Balner H. The technique of kidney transplantation in rhesus monkeys. J Med Primatol 1982; 11: 155.
28. Solez K, Axelsen RA, Benediktsson H, et al. International standardisation of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
29. Ossevoort MA, Ringers J, Boon L, et al. Blocking of costimulation prevents kidney graft rejection in rhesus monkeys. Transplant Proc 1998; 30: 2165.
30. Opelz G for the Collaborative Transplant Study. Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Transplantation 1995; 60: 1220.
31. Hale DA, Gottschalk R, Maki T, Monaco AP. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival. Transplantation 1997; 64: 897.
32. Van Saase JLCM, Van der Woude FJ, Thorogood J, et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995; 59: 1280.
33. Russel ME, Hancock WW, Akalin E, et al. Chronic cardiac rejection in the Lewis to F344 rat model: blockade of CD28-B7 costimulation by CTLA4-Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 1996; 97: 833.
34. Azuma H, Chandraker A, Nadeau K, et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Sci Acad USA 1996; 93: 12439.
35. Chandraker A, Russel ME, Glysing-Jensen T, Willett TA, Sayegh MH. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection. Transplantation 1997; 63: 1053.
36. Sun H, Subbotin V, Chen C, et al. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997; 64: 1838.
37. Pearson TC, Alexander DZ, Corbascio M, et al. Analysis of the B7 costimulatory pathway in allograft rejection. Transplantation 1997; 63: 1463.
38. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection. Transplantation 1996; 61: 4.